A Peptide Selected by Biopanning Identifies the Integrin αvβ6 as a Prognostic Biomarker for Nonsmall Cell Lung Cancer

Overview of attention for article published in Cancer Research, June 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

patent: 11 patents

Readers on

mendeley: 111 Mendeley

So far, Altmetric has seen 11 patents that reference this research output.

RNAi agents for inhibiting expression of receptor for advanced glycation end-products…

Grant US-12486502-B2

United States of America

02 Dec 2025

Alpha-v beta-6 integrin ligands and uses thereof

Grant US-12173086-B2

United States of America

24 Dec 2024

Integrin ligands and uses thereof

Grant US-11597701-B2

United States of America

07 Mar 2023

Bi-terminal pegylated integrin-binding peptides and methods of use thereof

Grant US-11485758-B2

United States of America

01 Nov 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 7 additional patents.